Antibiotic susceptibility and mechanisms of β-lactam resistance among clinical strains of Pseudomonas aeruginosa: First report in Algeria

Medecine et Maladies Infectieuses

Volumn 38, Issue 4, 2008, Pages 187-191

  Drissi, M ^a   Ahmed, Z Baba ^a   Dehecq, B ^c   Bakour, R ^b   Plesiat P ^c,d   Hocquet, D ^c,d  

^a UNIVERSITY OF TLEMCEN   (Algeria)

^b UNIVERSITY OF SCIENCES AND TECHNOLOGY HOUARI BOUMEDIENE   (Algeria)

^c UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^d UNIVERSITÉ DE FRANCHE COMTÉ   (France)

Author keywords

Multidrug resistant bacteria; Nosocomial infection; Pseudomonas aeruginosa

Indexed keywords

AMIKACIN; AZTREONAM; BETA LACTAM; BETA LACTAMASE; BETA LACTAMASE AMPC; BETA LACTAMASE TEM 1; CEFEPIME; CEFTAZIDIME; CEPHALOSPORINASE; CIPROFLOXACIN; CLOXACILLIN; GENTAMICIN; IMIPENEM; OXA 10 ENZYME; PIPERACILLIN PLUS TAZOBACTAM; TICARCILLIN; TIMENTIN; TOBRAMYCIN;

AGAR DILUTION; ALGERIA; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; ENZYME SYNTHESIS; GENOTYPE; INTENSIVE CARE UNIT; ISOELECTRIC FOCUSING; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; RANDOM AMPLIFIED POLYMORPHIC DNA; SEQUENCE ANALYSIS; SEROTYPING; UNIVERSITY HOSPITAL;

ALGERIA; DRUG RESISTANCE, BACTERIAL; GENOTYPE; HOSPITAL DEPARTMENTS; HOSPITALS, UNIVERSITY; LACTAMS; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; SEROTYPING;

EID: 43149096467     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2008.01.009     Document Type: Article

References (16)

1. Berthelot P., Grattard F., Mallaval F.O., Ros A., Lucht F., and Pozzetto B. Epidémiologie des infections nosocomiales à Pseudomonas aeruginosa, Burkholderia cepacia et Stenotrophomonas maltophilia. Pathol Biol 53 (2005) 341-348
2. Livermore D.M. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?. Clin Infect Dis 34 (2002) 634-640
3. Hocquet D., Berthelot P., Roussel-Delvallez M., Favre R., Jeannot K., Bajolet O., et al. Pseudomonas aeruginosa may accumulate drug resistance mechanisms without losing its ability to cause bloodstream infections. Antimicrob Agents Chemother 51 (2007) 3531-13531
4. Comité de l'Antibiogramme de la Société Française de Microbiologie (recommandation 2007), available on http://www.sfm.asso.fr [accessed 1.09.07].
5. Mahenthiralingam E., Campbell M.E., Foster J., Lam J.S., and Speert D.P. Random amplified polymorphic DNA typing of Pseudomonas aeruginosa isolates recovered from patients with cystic fibrosis. J Clin Microbiol 34 (1996) 1129-1135
6. Talon D., Mulin B., and Thouverez M. Clonal identification of Aeromonas hydrophila strains using randomly amplified polymorphic DNA analysis. Eur J Epidemiol 14 (1998) 305-310
7. Hocquet D., Bertrand X., Köhler T., Talon D., and Plésiat P. Genetic and phenotypic variations of a resistant Pseudomonas aeruginosa epidemic clone. Antimicrob Agents Chemother 47 (2003) 1887-1894
8. Bert F., Branger C., and Lambert-Zechovsky N. Identification of PSE and OXA β-lactamase genes in Pseudomonas aeruginosa using PCR-restriction fragment length polymorphism. J Antimicrob Chemother 50 (2002) 11-18
9. Pai H., Kim J., Lee J.H., Choe K.W., and Gotoh N. Carbapenem resistance mechanisms in Pseudomonas aeruginosa clinical isolates. Antimicrob Agents Chemother 45 (2001) 480-484
10. Quale J., Bratu S., Gupta J., and Landman D. Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates. Antimicrob Agents Chemother 50 (2006) 1633-1641
11. Lee K., Lim Y.S., Yong D., Yum J.H., and Chong Y. Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-β-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol 41 (2003) 4623-4629
12. European Antimicrobial Resistance Surveillance System, available on http://www.rivm.nl/earss [accessed 1.09.07].
13. Gutiérrez O., Juan C., Cercenado E., Navarro F., Bouza E., Coll P., et al. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals. Antimicrob Agents Chemother 51 (2007) 4329-4335
14. Neuhauser M.M., Weinstein R.A., Rydman R., Danziger L.H., Karam G., and Quinn J.P. Antibiotic resistance among Gram-negative bacilli in US intensive care units: implications for fluoroquinolone use. JAMA 289 (2003) 885-888
15. Ouar-Korichi M., Assaous F., Gilly L., Paul G., and Rahal K. Extended-spectrum β-lactamase among non-typhoidic Salmonella in paediatric unit of Algerian hospital. Abstract. European Congress of Clinical Microbiology and Infectious Diseases. Munich (2007)
16. Amazian K., Fendri C., Missoum M.F., Bouzouaia N., Rahal K., Savey A., et al. Multicenter pilot survey of resistant bacteria in the Mediterranean area. Eur J Clin Microbiol Infect Dis 25 (2006) 340-343